These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10548140)

  • 21. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and management of the obese adult female: a clinical update for providers.
    Salazar SS
    J Midwifery Womens Health; 2006; 51(3):202-7. PubMed ID: 16647672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does prior authorization of sibutramine improve medication compliance or weight loss?
    Risser JA; Vash PD; Nieto L
    Obes Res; 2005 Jan; 13(1):86-92. PubMed ID: 15761166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
    Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S; Richelsen B
    Ugeskr Laeger; 2006 Jan; 168(2):175-9. PubMed ID: 16403345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What effect does losing weight have on hypertension?].
    Engeli S
    MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
    [No Abstract]   [Full Text] [Related]  

  • 29. [A drug help in reducing? Risk profile decides whether and how].
    Hauner H
    MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
    [No Abstract]   [Full Text] [Related]  

  • 30. Diets, drugs, exercise, and behavioral modification: Where these work and where they do not.
    Kushner R
    Surg Obes Relat Dis; 2005; 1(2):120-2. PubMed ID: 16925226
    [No Abstract]   [Full Text] [Related]  

  • 31. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of obesity.
    Piziak VK
    Compr Ther; 1987 Jan; 13(1):7-12. PubMed ID: 3802754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
    Gursoy A; Erdogan MF; Cin MO; Cesur M; Baskal N
    Eat Weight Disord; 2006 Dec; 11(4):e127-32. PubMed ID: 17272944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of obesity: medical treatment options.
    Carek PJ; Sherer JT; Carson DS
    Am Fam Physician; 1997 Feb; 55(2):551-8, 561-2. PubMed ID: 9054224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive psychological approach to obesity.
    Fawzy FI; Pasnau RO; Wellisch DK; Ellsworth RG; Dornfeld L; Maxwell M
    Psychiatr Med; 1983 Sep; 1(3):257-73. PubMed ID: 6400602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prudent and practical approach to the treatment of obesity.
    Kern PA
    J Ark Med Soc; 1997 Oct; 94(5):191-7. PubMed ID: 9343968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring synergies in the treatment of obesity.
    Wadden TA
    Postgrad Med; 2001 Jun; 109(6 Suppl):29-33. PubMed ID: 19667565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical management of obesity.
    Berke EM; Morden NE
    Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for the treatment of obesity.
    Proietto J
    Med J Aust; 1992 Sep; 157(6):363-4. PubMed ID: 1307233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.